The clinical recommendations are evidence-based and consensus-based guidelines for Duchenne muscular dystrophy (DMD) patient care in the UK, agreed by each DMD Care UK working group. 

All recommendations have been based on the International DMD Care Considerations 2018 published in the Lancet Neurology: Part 1, Part 2 and Part 3but are more specific and relevant for the UK healthcare system.